{"id":3542,"date":"2018-02-13T16:58:19","date_gmt":"2018-02-13T13:58:19","guid":{"rendered":"https:\/\/umram.bilkent.edu.tr\/?p=3542"},"modified":"2018-09-12T16:59:26","modified_gmt":"2018-09-12T13:59:26","slug":"farnesilyosalicyclic-acid-iceren-nanopartik-formulasyon-baslikli-avrupa-patent-basvurusu-tescillendi","status":"publish","type":"post","link":"https:\/\/umram.bilkent.edu.tr\/index.php\/tr\/2018\/02\/13\/farnesilyosalicyclic-acid-iceren-nanopartik-formulasyon-baslikli-avrupa-patent-basvurusu-tescillendi\/","title":{"rendered":"FARNESILYOSALICYCLIC ACID \u0130\u00c7EREN NANOPART\u0130K FORM\u00dcLASYON&#8221; ba\u015fl\u0131kl\u0131 Avrupa patent ba\u015fvurusu tescillendi."},"content":{"rendered":"<p>&#8220;FARNESILYOSALICYCLIC ACID \u0130\u00c7EREN NANOPART\u0130K FORM\u00dcLASYON&#8221; ba\u015fl\u0131kl\u0131 Avrupa patent ba\u015fvurusu (WO2015167408) (PCT \/ TR2014 \/ 000248) olumlu sonu\u00e7lanm\u0131\u015f ve tescil karar\u0131 tamamlanm\u0131\u015ft\u0131r. Yeni jenerasyonlu bir antineoplastik ajan olan Farnesiltiyosalisilik asit (Salirasib, FT A), malign t\u00fcm\u00f6rlerin \u00e7o\u011funda y\u00fcksek oranda bulunan, Ras proteininin spesifik bir \u00f6nleyicisidir. Patentlenebilir \u00e7al\u0131\u015fma, hastal\u0131\u011f\u0131n durumunu, al\u0131m\u0131n\u0131 veya etkinli\u011fini de\u011fi\u015ftirmek i\u00e7in hedeflenmi\u015f bir kemoterapidir. Antineoplastik ila\u00e7lar\u0131, normal h\u00fccrelerden ziyade t\u00fcm\u00f6r h\u00fccrelerine daha fazla hasar sa\u011flayarak yok eder. Eski UMRAM ara\u015ft\u0131rmac\u0131s\u0131 Taner Demir ve UMRAM Profes\u00f6r\u00fc Kader Karl\u0131 O\u011fuz bulu\u015f sahipleri aras\u0131nda yer almaktad\u0131r. Di\u011fer yazarlar aras\u0131nda Hacettepe \u00dcniversitesi T\u0131p Fak\u00fcltesi akademisyenlerinden Sibel PEHL\u0130VAN, \u0130mran VURAL, Melike Mut A\u015eKUN, Figen S\u00d6YLEMEZO\u011eLU yan\u0131s\u0131ra Abbas KAFFASHI, Sevda L\u00dcLE, H\u00fcsn\u00fc KO\u015eUCU, Can SARIS\u00d6ZEN bulunmaktad\u0131r.\u00a0<a href=\"http:\/\/www.umram.bilkent.edu.tr\/Hacettepe%20%C3%9Cniversitesi%20T%C4%B1p%20Fak%C3%BCltesi%20\" target=\"_blank\" rel=\"noopener\">Patent i\u00e7in :<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&#8220;FARNESILYOSALICYCLIC ACID \u0130\u00c7EREN NANOPART\u0130K FORM\u00dcLASYON&#8221; ba\u015fl\u0131kl\u0131 Avrupa patent ba\u015fvurusu (WO2015167408) (PCT \/ TR2014 \/ 000248) olumlu sonu\u00e7lanm\u0131\u015f ve tescil karar\u0131 tamamlanm\u0131\u015ft\u0131r. Yeni jenerasyonlu bir antineoplastik ajan olan Farnesiltiyosalisilik asit (Salirasib, FT A), malign t\u00fcm\u00f6rlerin \u00e7o\u011funda y\u00fcksek oranda bulunan, Ras proteininin spesifik bir \u00f6nleyicisidir. Patentlenebilir \u00e7al\u0131\u015fma, hastal\u0131\u011f\u0131n durumunu, al\u0131m\u0131n\u0131 veya etkinli\u011fini de\u011fi\u015ftirmek i\u00e7in hedeflenmi\u015f bir kemoterapidir. [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":3540,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[445],"tags":[],"_links":{"self":[{"href":"https:\/\/umram.bilkent.edu.tr\/index.php\/wp-json\/wp\/v2\/posts\/3542"}],"collection":[{"href":"https:\/\/umram.bilkent.edu.tr\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/umram.bilkent.edu.tr\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/umram.bilkent.edu.tr\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/umram.bilkent.edu.tr\/index.php\/wp-json\/wp\/v2\/comments?post=3542"}],"version-history":[{"count":1,"href":"https:\/\/umram.bilkent.edu.tr\/index.php\/wp-json\/wp\/v2\/posts\/3542\/revisions"}],"predecessor-version":[{"id":3543,"href":"https:\/\/umram.bilkent.edu.tr\/index.php\/wp-json\/wp\/v2\/posts\/3542\/revisions\/3543"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/umram.bilkent.edu.tr\/index.php\/wp-json\/wp\/v2\/media\/3540"}],"wp:attachment":[{"href":"https:\/\/umram.bilkent.edu.tr\/index.php\/wp-json\/wp\/v2\/media?parent=3542"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/umram.bilkent.edu.tr\/index.php\/wp-json\/wp\/v2\/categories?post=3542"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/umram.bilkent.edu.tr\/index.php\/wp-json\/wp\/v2\/tags?post=3542"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}